These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 5529307

  • 21. End stage renal disease and prophylactic intracavitary interferon.
    Pascual J, Quereda C, Burgos FJ, Liaño F, Mampaso F, Frutos B, Ortuño J.
    J Urol; 1997 Sep; 158(3 Pt 1):881. PubMed ID: 9258104
    [No Abstract] [Full Text] [Related]

  • 22. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH.
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [Abstract] [Full Text] [Related]

  • 23. [Long-term intravesical treatment with adriamycin in chemoprevention of recurrence of transurethrally resected urinary bladder cancers].
    Flamm J, Grof F.
    Wien Med Wochenschr; 1987 Jul 15; 137(13):315-7. PubMed ID: 3114964
    [Abstract] [Full Text] [Related]

  • 24. [Problems of recurrence of bladder tumor].
    Niijima T.
    Nihon Ishikai Zasshi; 1971 Sep 15; 66(5):497-502. PubMed ID: 5165600
    [No Abstract] [Full Text] [Related]

  • 25. Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer.
    Zang Z, Xu H, Yu L, Yang D, Xie S, Shi Y, Li Z, Li J, Wang J, Li M, Guo Y, Gu F.
    Chin Med J (Engl); 2000 Nov 15; 113(11):1002-6. PubMed ID: 11776112
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the efficacy of oral methotrexate in the prevention of recurrence of superficial bladder tumours.
    Nogueira March JL, Ojea A, Figueiredo L, Jamardo D, Diez E, Perez Villanueva J.
    Br J Urol; 1985 Jun 15; 57(3):306-7. PubMed ID: 4005499
    [Abstract] [Full Text] [Related]

  • 27. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K, Alfthan O.
    Ann Chir Gynaecol; 1984 Jun 15; 73(4):206-10. PubMed ID: 6508201
    [Abstract] [Full Text] [Related]

  • 28. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep 15; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 32. [Prophylactic effect of UFT on the recurrence of bladder cancer].
    Naito K, Hisazumi H, Saka A, Nakamura T, Kanda S, Mikawa I, Ejiri S, Miyagi T, Katsumi T, Kitagawa K.
    Hinyokika Kiyo; 1990 Apr 15; 36(4):487-94. PubMed ID: 2116083
    [Abstract] [Full Text] [Related]

  • 33. Low dose intravesical heparin as prophylaxis against recurrent noninvasive (stage Ta) bladder cancer.
    Bitsch M, Hermann GG, Andersen JP, Steven K.
    J Urol; 1990 Sep 15; 144(3):635-6. PubMed ID: 2201794
    [Abstract] [Full Text] [Related]

  • 34. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa.
    Prout GR, Koontz WW, Coombs LJ, Hawkins IR, Friedell GH.
    J Urol; 1983 Oct 15; 130(4):677-80. PubMed ID: 6411939
    [Abstract] [Full Text] [Related]

  • 35. [Intravesical bacillus Calmette-Guerin instillation therapy in superficial bladder cancers--clinical study on prognostic factors].
    Shinka T, Hirano A, Uekado Y, Ohkawa T.
    Nihon Hinyokika Gakkai Zasshi; 1990 Mar 15; 81(3):425-32. PubMed ID: 2359220
    [Abstract] [Full Text] [Related]

  • 36. The effect of urinary -glucuronidase inhibition on the induction of bladder tumors with 2-acetylaminofluorene in rats.
    Miyakawa M, Yoshida O, Harada T, Kato T.
    Invest Urol; 1973 Jan 15; 10(4):256-61. PubMed ID: 4683376
    [No Abstract] [Full Text] [Related]

  • 37. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
    Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA.
    J Urol; 1978 Oct 15; 120(4):410-1. PubMed ID: 100615
    [Abstract] [Full Text] [Related]

  • 38. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
    Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM.
    Clin Cancer Res; 2008 Jan 01; 14(1):224-9. PubMed ID: 18172274
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Chemoimmune prophylaxis of superficial bladder cancer.
    Adolphs HD, Bastian HP.
    J Urol; 1983 Jan 01; 129(1):29-32. PubMed ID: 6827684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.